key: cord-1044264-flph04ns authors: Hermans, Astrid N. L.; van der Velden, Rachel M. J.; Gawalko, Monika; Verhaert, Dominique V. M.; Desteghe, Lien; Duncker, David; Manninger, Martin; Heidbuchel, Hein; Pisters, Ron; Hemels, Martin; Pison, Laurent; Sohaib, Afzal; Sultan, Arian; Steven, Daniel; Wijtvliet, Petra; Tieleman, Robert; Gupta, Dhiraj; Dobrev, Dobromir; Svennberg, Emma; Crijns, Harry J. G. M.; Pluymaekers, Nikki A. H. A.; Hendriks, Jeroen M.; Linz, Dominik title: On‐demand mobile health infrastructures to allow comprehensive remote atrial fibrillation and risk factor management through teleconsultation date: 2020-10-08 journal: Clin Cardiol DOI: 10.1002/clc.23469 sha: 555e6ac9008e0d73375e6252321b0c370f56417f doc_id: 1044264 cord_uid: flph04ns BACKGROUND: Although novel teleconsultation solutions can deliver remote situations that are relatively similar to face‐to‐face interaction, remote assessment of heart rate and rhythm as well as risk factors remains challenging in patients with atrial fibrillation (AF). Hypothesis. Mobile health (mHealth) solutions can support remote AF management. METHODS: Herein, we discuss available mHealth tools and strategies on how to incorporate the remote assessment of heart rate, rhythm and risk factors to allow comprehensive AF management through teleconsultation. RESULTS: Particularly, in the light of the coronavirus disease 2019 (COVID‐19) pandemic, there is decreased capacity to see patients in the outpatient clinic and mHealth has become an important component of many AF outpatient clinics. Several validated mHealth solutions are available for remote heart rate and rhythm monitoring as well as for risk factor assessment. mHealth technologies can be used for (semi‐)continuous longitudinal monitoring or for short‐term on‐demand monitoring, dependent on the respective requirements and clinical scenarios. As a possible solution to improve remote AF care through teleconsultation, we introduce the on‐demand TeleCheck‐AF mHealth approach that allows remote app‐based assessment of heart rate and rhythm around teleconsultations, which has been developed and implemented during the COVID‐19 pandemic in Europe. CONCLUSION: Large scale international mHealth projects, such as TeleCheck‐AF, will provide insight into the additional value and potential limitations of mHealth strategies to remotely manage AF patients. Such mHealth infrastructures may be well suited within an integrated AF‐clinic, which may require redesign of practice and reform of health care systems. Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia and is associated with increased risk of heart failure, stroke, bleeding, acute coronary syndrome and severe adverse effects of antiarrhythmic drugs, all of which may lead to unplanned cardiovascular hospitalization, morbidity and mortality. [1] Management of AF risk factors and monitoring of vital parameters, particularly heart rate and rhythm, are important for the management of AF patients and prevention of AFrelated morbidity. [2] Remote monitoring by means of novel technologies provides an opportunity to bring the best standard of care and expertise to the patient rather than the patient having to visit an outpatient clinic. This may be particularly important for the management of patients who live remotely and far away from coordinating medical centers or during catastrophes, including coronavirus disease 2019 , when attendance of outpatient clinics or traveling to the hospital is not possible or undesirable. [3] Although new teleconsultation solutions can produce remote situations that are relatively similar to face-to-face interaction, the remote assessment of heart rate and rhythm as well as risk factors remains challenging. In this review article, we discuss mobile health (mHealth) tools and strategies to remotely monitor heart rate and rhythm and incorporate AF risk factors assessment to allow comprehensive AF management through teleconsultation. Additionally, as a possible solution to improve remote AF care during the COVID-19 pandemic, we introduce the on-demand TeleCheck-AF mHealth approach that allows remote app-based assessment of heart rate and rhythm around teleconsultations. Different mHealth tools are available for remote heart rate and rhythm assessment. Until now, most tools are available within a patient-initiated paying-model which, together with the absence of reimbursement, complicates the clinical implementation and guidance of mHealth use by the treating physician. Additionally, the requirements on the way when and how to perform measurements (semi-continuous vs on-demand ( Figure 1 ) and electrocardiography (ECG) vs photoplethysmography (PPG), respectively) are critically dependent on the clinical scenario and setting. As this is difficult for patients to judge, a physician-initiated or at least -guided approach appears to be necessary to allow personalized mHealth use and the selection of the right tool for each patient. To screen for AF, (semi-)continuous remote monitoring by cardiac implantable electronic devices (CIEDs), wearables (eg, smart watches), handheld devices (eg, AliveCor, MyDiagnostick, etc.) or app-based mHealth solutions using PPG technology through the smartphone's built-in camera (eg, FibriCheck) have been developed and validated ( Figure 2 ). Smartwatches such as Fitbit and Apple Watch, equipped with PPG technology, are commonly used for semi-continuous heart rate and rhythm monitoring during day and night and have a valuable clinical effect by enabling AF detection in both symptomatic and asymptomatic patients. [4] [5] [6] Most of the devices are CE marked and some of them are connected to secured and certified clouds, allowing remote access of the data by treating physicians or allied healthcare professionals. PPG technology is not sufficient to diagnose AF. Based on the current international AF Guidelines of the European Society of Cardiology (ESC), [2] ECGdocumentation of an AF episode is required for diagnosis. As most PPG algorithms are developed for AF screening scenarios, they operate in a high sensitivity mode, resulting in a higher number of false positive recordings. [7] Therefore, in the setting of AF screening, PPG-detected episodes suggestive of AF need to be confirmed by an ECG. Despite crucial differences between PPG and ECG F I G U R E 1 Remote heart rate and rhythm monitoring: (semi-) continuous longitudinal vs ondemand F I G U R E 2 Different mobile health devices technologies for heart rhythm monitoring, most of the PPG-based algorithms are validated to detect AF with a high sensitivity and specificity. [7] Additionally, there is already some data that PPG technology is nearly as accurate as ECG to detect AF. [8, 9] In the validation studies for these devices, atrial high rate episodes (AHRE) from CIEDs have not been taken into account. Given the wide availability and low cost, PPG technology may represent an optimal screening tool to detect AF, which can then be confirmed by ECG technology afterwards in a second step. While PPG technology has limitations to diagnose AF, the wide accessibility and low cost of this technology via smartphone apps makes it an interesting tool for remote heart rate and rhythm monitoring of patients who have already been diagnosed with AF. A temporary pre-determined on-demand approach, where heart rate and rhythm information are provided to the health care provider just before a scheduled appointment appears to fulfill most requirements to manage AF patients remotely through teleconsultation. This ondemand, rather than unfocused long-term monitoring enables an ideal remote consultation with helpful and crucial well-timed heart rate and rhythm information available for the treating physician, nurse or allied healthcare professional to steer management of patients with ECG-documented AF. For an on-demand mHealth approach, apps can be activated "on prescription" and linked to a secured cloud, which is accessible by the treating physician or nurse. Additionally, simultaneous monitoring of heart rhythm and symptoms provides information about symptom-rhythm correlation. Onprescription monitoring increases awareness with the patients who are better prepared for the remote consultation: patients know that symptom and rhythm evaluation is on the agenda during the consultation, together with discussions on necessary treatments. An ondemand monitoring approach also avoids unnecessary data load, which would require work-intensive and expensive data management infrastructures. Management of risk factors is an important component of AF treatment. Despite convincing evidence for the need of risk factor management in AF patients, [10] it remains unclear, how best to assess risk factors and guide risk factor management and lifestyle modification in a remote setting. [11] Established risk factors are often assessed only once in a structured way at the time point when AF patients present for the first time in the AF-clinic (spot-assessment of risk factors). However, several AF risk factors may show a high visit-to-visit or even day-to-day variability and lifestyle components such as physical activity, diet and sleep behaviors may be variable over time. [11] [12] [13] [14] [15] [16] [17] This visit-to-visit or day-to-day variability does not just complicate the detection of AF risk factors but may also have a prognostic implication. High visit-to-visit variability in risk factors is associated with increased risk of incident new-onset AF, worse cardiovascular outcome and increased mortality. [18] [19] [20] Hence, assessment of risk factors requires a longitudinal and remote structured monitoring infrastructure ( Figure 3 ). Additionally, longitudinal documentation of risk factors during a risk factor modification program may allow monitoring of the response to the intervention and adaptation and guidance as required to optimize the results. For the implementation of remote and longitudinal assessment of risk factors and lifestyle components, mHealth applications and technologies such as activity trackers, Bluetooth-linked balances, blood pressure devices and diary apps to assess diet may provide the required infrastructures. Smartphone apps as well as smartwatches already provide longitudinal information about most lifestyle components and some risk factors. The smartphone app "Health Buddies application" [21] or a computer-animated application designed by Magnani et al. [22] resulted in increased adherence to oral anticoagulation and improved quality of life in AF patients. A meta-analysis of 51 randomized F I G U R E 3 Intermittent shortterm monitoring for longitudinal risk factor assessment. The blue boxes indicate periods of intermittent short-term monitoring before scheduled teleconsultations controlled trials demonstarted that compared with usual care, mHealth interventions in diabetes and hypertension management yielded significant mean differences in clinical outcomes including blood pressure, fasting blood glucose and HbA1c control and had positive effects on improving quality of life, satisfaction and self-efficacy. [23, 24] However, until now, these apps are almost exclusively patient-initiated and not implemented in structured patient care pathways. Therefore, most of the apps remain as lifestyle products and have not found their way to clinical implementation. Another emerging modifiable AF risk factor is sleep apnea. [25] Technologies implemented in implantable devices, on-contact biomotion sensors with actimetry, ballistic sensors or Doppler technology with radar frequencies can remotely monitor breathing during sleep. [26, 27] Wearable devices with inbuilt pulse oximeters are now also becoming commercially available raising the prospect of routinely measuring the night-to-night variability of sleep disordered breathing severity by means of the oxygen desaturation index or determining hypoxic burden more broadly by newer validated algorithms. [17, 28] Several clinical trials have demonstrated the feasibility of mHealth-based sleep apnea management compared with a more traditional in-person care model, suggesting non-inferiority in terms of adherence to continuous positive airway pressure treatment and compliance as well as functional outcomes such as satisfaction and cost-effectiveness. [29, 30] Technologies for longitudinal monitoring of lifestyle components and AF risk factors are available and may support a more complete remote assessment and management of AF patients in the future, once these tools can be implemented in existing clinical pathways or emerging mHealth approaches. In addition to the assessment of risk factors, mHealth infrastructures and apps can also be helpful in applying dedicated in-app coaching to improve lifestyle and control risk factors by behavioral changes. [31] Besides this, telemonitoring can also optimize medication adherence. [32] Integrated care has been recognized as a suitable approach to manage patients with chronic conditions and complex treatments, such as AF, in international guidelines of the ESC for the management of AF. [33, 34] Implementation of teleconsultation and the use of mHealth solutions should be embedded within this integrated care approach, whilst adhering to the following four fundamental components: 1) The use of technology by means of eHealth or mHealth. This aims to support and guide the patient through the care process (eg, patient education and instruction) as well as the treatment team (smart technology to support decision making). [35] In fact, such technology solutions should support integrated care in terms of actively involving patients in their care process, collaboration within multidisciplinary teams, and provide guidance in the complex (shared) treatment decisions and coordination of care. 2) Active involvement of the patient is promoted through the mHealth solutions. The role of the patient in an mHealth infrastructure is crucial, as the treatment team relies on the patient to use the infrastructure and collect and provide data on vital parameters such as heart rate and rhythm as well as symptoms and potential risk factors. However, before patients can take on such a task, they should be educated and clearly instructed, so they understand what is expected from them. 3) The treatment may be provided by a multidisciplinary treatment team. This team consists of cardiologists, nurses, primary care physician and other specialists that might be involved in the management of AF, depending on the individual case. Infrastructure for such an approach might be available in terms of a specialized AF-clinic, [36] where cardiologists and specialized nurses would work closely with the patient, in a face to face setting or via teleconferencing, aiming to improve efficiency and outcomes. [37] Communication is key in such teams to assure that all team members understand their role and contribution, and that there is a designated care coordinator. Depending on the context this may be a nurse within the AF-clinic or administrative staff. 4) The final component of integrated care is the delivery of comprehensive treatment. Besides the management of AF (ie, heart rate and/or rhythm control strategy to improve symptoms) alone, it is crucial to determine the potential stroke risk and prescribe appropriate oral anticoagulation accordingly to prevent thromboembolic complications; management of precipitating factors (such as underlying cardiovascular conditions and modifiable risk factors) to reduce the cardiovascular burden to consequently reduce the AF burden. [33, [38] [39] [40] These four fundamentals form the basis of an integrated AF care approach and the use of mHealth solutions through teleconsultations, seamlessly fits within an AF-clinic as well as with the aims of integrated care: improving outcomes while preventing fragmentation of care. One possible pathway to implement an on-demand mHealth infrastructure for remote heart rate, rhythm and risk factor assessment to allow comprehensive AF management through teleconsultation is shown in Figure 4 . TeleCheck-AF is an on-demand mHealth intervention incorporating an app-based heart rate and rhythm monitoring infrastructure to allow remote AF management through teleconsultation. During the COVID-19 pandemic, it was made available in several European centres to keep AF patients out of the hospital (see Figure 5 ). [39, 41, 42] TeleCheck-AF involves a structured teleconsultation ("Tele") preceded by an appbased on-demand heart rate and rhythm monitoring infrastructure ("Check") to guarantee comprehensive AF management ("AF"). [39] The Conformité Européenne (CE)-marked PPG-based mobile phone app (www.fibricheck.com) allows semi-continuous heart rate and rhythm monitoring of AF patients for 7 days prior to and during the teleconsultation. One important advantage of TeleCheck-AF compared to other systems of telemonitoring is the on-demand mHealth approach. [43] It enables the physicians to use heart rate and rhythm data for treatment decisions and prevents unnecessary data collection which would be the case with continuous long-term heart rate and rhythm telemonitoring systems (eg, wearables devices or CIEDs), and which need to be managed afterwards requiring workintensive and expensive data management infrastructures. Additionally, the on-demand heart rate and rhythm monitoring approach empowers patients to monitor their vital parameters and selfmanage their condition. Patients are involved in making decisions about measurement time and number of measurements during the day, that depends in particular on the presence of symptoms. Furthermore, the TeleCheck-AF approach provides crucial information about symptom-rhythm correlation by simultaneous rhythm and symptom assessment to steer appropriate AF management. The TeleCheck-AF infrastructure can be combined with other available app-based risk factor assessment tools, to allow the comprehensive remote assessment and management of AF patients. Implementation of mHealth infrastructures require adaptation of existing care coordination and clinical pathways. [43] An important element for embedding mHealth in clinical practice is the accessibility of the recordings by other healthcare professionals. For this, a connection with the patients' electronic healthcare record is crucial. This connection facilitates automatic transmission of the recordings from the secured cloud to the electronic healthcare record of the patient and increases the accessibility of the data for other healthcare professionals. Additionally, many AF apps lack scientific validation and are written at excessively high reading-grade levels challenging users with limited health literacy. Although mHealth solutions for heart rate and rhythm monitoring are clinically established and used, apps for longitudinal risk factor assessment are not available and were therefore not yet incorporated in the TeleCheck-AF approach. Finally, a multidisciplinary effort by regulatory agencies, healthcare organizations, and app stores is required to improve relevance, scientific validity, and readability of AF apps for AF patients. [44] Additionally, discussions with insurance companies about reimbursement of mHealth infrastructures and with different stakeholders to agree on security and privacy regulations are initiated in different countries. [31, 45] 7 | CONCLUSION Health tools in the management of AF are becoming indispensable in current healthcare. Novel tools are able to remotely assess heart rate F I G U R E 4 Remote heart rate, rhythm and risk factor assessment by the use of mobile health solutions through teleconsultation F I G U R E 5 The TeleCheck-AF project and rhythm and incorporate AF risk factor assessment to allow comprehensive AF management through teleconsultation. TeleCheck-AF is one, but not the only possible solution to improve remote AF care during the COVID-19 pandemic and will provide insight into the additional value and potential limitations of mHealth strategies to remotely manage AF patients. Such mHealth infrastructures may be well suited within an integrated AF-clinic, which may require redesign of practice and reform of health care systems. Atrial fibrillation: JACC council perspectives ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS) AHA worldwide practice update for telehealth and arrhythmia monitoring during and after a pandemic Photoplethysmography based atrial fibrillation detection: a review Screening for atrial fibrillation: a call for evidence Role of wearable rhythm recordings in clinical decision making-the wEHRAbles project Accuracy of smartphone camera applications for detecting atrial fibrillation: a systematic review and meta-analysis Diagnostic performance of a smartphone-based Photoplethysmographic application for atrial fibrillation screening in a primary care setting Comparison between electrocardiogram-and photoplethysmogram-derived features for atrial fibrillation detection in free-living conditions Risk factor management in atrial fibrillation A call for a more objective and longitudinal reporting of lifestyle components in cardiovascular research Variability of sleep apnea severity and risk of atrial fibrillation. The VARIOSA-AF Study J Am College Cardiol Nightly variation in sleep apnea severity as atrial fibrillation risk PREVEntion and regReSsive effect of weight-loss and risk factor modification on atrial fibrillation: the REVERSE-AF study Age modifies the risk of atrial fibrillation among athletes: a systematic literature review and meta-analysis Gender differences and daily variation in atrial fibrillation risk factor profiles: considerations for risk factor management Composition of nocturnal hypoxaemic burden and its prognostic value for cardiovascular mortality in older community-dwelling men Blood pressure variability and incidence of new-onset atrial fibrillation: a Nationwide population-based study Effect of the variability of blood pressure, glucose level, total cholesterol level, and body mass index on the risk of atrial fibrillation in a healthy population High variability in bodyweight is associated with an increased risk of atrial fibrillation in patients with type 2 diabetes mellitus: a nationwide cohort study The health buddies app as a novel tool to improve adherence and knowledge in atrial fibrillation patients: a pilot study The atrial fibrillation health literacy information technology system: pilot assessment The clinical outcomes and effectiveness of mHealth interventions for diabetes and hypertension: a systematic review and meta-analysis A systematic review of mobile health technologies to support self-management of concurrent diabetes and hypertension Associations of obstructive sleep apnea with atrial fibrillation and continuous positive airway pressure treatment: a review Nightly sleep apnea severity in patients with atrial fibrillation: potential applications of long-term sleep apnea monitoring The why, when and how to test for obstructive sleep apnea in patients with atrial fibrillation Diagnostic accuracy of overnight oximetry for the diagnosis of sleep-disordered breathing in atrial fibrillation patients Mobile health application to support CPAP therapy in obstructive sleep apnoea: design, feasibility and perspectives Overview of smartphone applications for sleep analysis Mobile health technology for atrial fibrillation management integrating decision support, education, and patient involvement: mAF app trial Telemonitoring-based feedback improves adherence to non-vitamin K antagonist oral anticoagulants intake in patients with atrial fibrillation ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the diagnosis and management of atrial fibrillation Mobile health technology to improve care for patients with atrial fibrillation An integrated chronic care program for patients with atrial fibrillation: study protocol and methodology for an ongoing prospective randomised controlled trial Improving guideline adherence in the treatment of atrial fibrillation by implementing an integrated chronic care program National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the diagnosis and Management of Atrial Fibrillation Implementation of an on-demand app-based rate and rhythm monitoring infrastructure for the management of atrial fibrillation through teleconsultation: TeleCheck-AF Oral anticoagulant use for stroke prevention in atrial fibrillation patients with difficult scenarios On-demand app-based rate and rhythm monitoring to manage atrial fibrillation through teleconsultations during COVID-19 investigators obotT-A. TeleCheck-AF for COVID-19: a European mHealth project to facilitate atrial fibrillation management through teleconsultation during COVID19 Coordination of a remote mHealth infrastructure for atrial fibrillation management during COVID-19 and beyond: TeleCheck-AF Mobile health applications for atrial fibrillation: a readability and quality assessment Sleep apnea testing and Management in Patients with Atrial Fibrillation: why is it so difficult? How to cite this article: Hermans ANL, van der Velden RMJ On-demand mobile health infrastructures to allow comprehensive remote atrial fibrillation and risk factor management through teleconsultation The authors declare that there is no conflicts of interests. Data sharing not applicable to this article as no datasets were generated or analysed during the current study.